The Clock-Drawing Test (CDT) has been used to screen for Alzheimer’s disease (AD) as a supplement to cognitive tests that focus on memory impairment. We examined a comprehensive scoring system of the CDT in screening of AD in a Chinese population and derived a simplified scoring system. All 403 (144 AD and 259 nondemented) subjects were administered the CDT, including both the drawing part (CDT-D) and the copying part (CDT-C). The Cognitive Abilities Screening Instrument and the Clinical Dementia Rating were also administered. Stepwise discriminant analysis was used to develop a simplified CDT scoring system. The optimal CDT cutoff scores (CDT-D: 10/11; CDT-C: 12/13) show intermediate sensitivity (CDT-D: 66.7%; CDT-C: 51.4%) and specificity (CDT-D: 74.5%; CDT-C: 74.1%). The simplified 3-item CDT scoring system, with a cutoff score of 2/3, has a sensitivity of 72.9% and a specificity of 65.6%; it can be used as a quick test for AD screening.

Keywords:
Alzheimer’s disease, Clock-Drawing Test, Cutoff, Screening
1.
Folstein M, Folstein S, McHugh P: ‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
2.
Teng EL, Hasegawa K, Homma A, Imai Y, Larson EB, Graves AB, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D, White LR: The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45–58.
3.
Liu HC, Chou P, Lin KN, Wang SJ, Fuh JL, Lin HC, Liu CY, Wu GS, Larson EB, White LR, Graves AB, Teng EL: Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med 1994;24:763–770.
4.
Tombaugh TN, McIntyre NJ: The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 1992;40:922–935.
5.
Tangalos EG, Smith GE, Ivnik RJ, Petersen RC, Kokmen E, Kurland LT, Offord KP, Parisi JE: The Mini-Mental State Examination in general medical practice: Clinical utility and acceptance. Mayo Clin Proc 1996;71:829–837.
6.
Liu HC, Teng EL, Lin KN, Hsu TC, Guo NW, Chou P, Hu HH, Cheng WN, Chiang BN: Performance on a dementia screening test in relation to demographic variables: Study of 5,297 community residents in Taiwan. Arch Neurol 1994;51:910–915.
7.
Shulman K: Clock-Drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15:548–561.
8.
Borson S, Brush M, Gil E, Scanlan J, Vitaliano P, Chen J, Cashman J, Sta Maria M, Barnhart R, Roques J: The Clock Drawing Test: Utility for dementia detection in multiethnic elders. J Gerontol A Biol 1999;54A:M534–M540.
9.
Mendez MF, Ala T, Underwood KL: Development of scoring criteria for the clock drawing task in Alzheimer’s disease. J Am Geriatr Soc 1992;40:1095–1099.
10.
Shulman KI, Gold DP, Cohen CA, Zucchero CA: Clock-drawing and dementia in the community: A longitudinal study. Int J Geriatr Psychiatry 1993;8:487–496.
11.
Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer BA, Newhouse PA, Grafman JH: Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc 1989;37:725–729.
12.
Watson YI, Arfken CL, Birge SJ: Clock completion: An objective screening test for dementia. J Am Geriatr Soc 1993;41:1235–1240.
13.
Wolf-Klein GP, Silverstone FA, Levy AP, Brod M: Screening for Alzheimer’s disease by clock drawing. J Am Geriatr Soc 1989;37:730–734.
14.
Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL: The clock test: A sensitive measure to differentiate normal elderly from those with Alzheimer’s disease. J Am Geriatr Soc 1992;40:579–584.
15.
Schlotterer GS, Moscovitch M, Crapper-McLachlan D: Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal aging and Alzheimer’s disease. Brain 1984;107:309–325.
16.
Moore V, Wyke MA: Drawing disability in patients with senile dementia. Psychol Med 1984;14:97–105.
17.
Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K: Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain Cognition 1992;18:70–87.
18.
Lam CW L, Chiu FK H, Ng KO, Chan C, Chan WF, Li SW, Wong M: Clock-face drawing, reading and setting tests in the screening of dementia in Chinese elderly adults. J Gerontol B Psychol 1998;53B:P353–P357.
19.
Förstl H, Bruns A, Levy R, Cairns N: Neuropathological basis for drawing disability (constructional apraxia) in Alzheimer’s disease. Psychol Med 1993;23:623–629.
20.
Agrell B, Dehlin O: The clock-drawing test. Age Ageing 1998;27:399–403.
21.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
22.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
23.
Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
24.
Morris JC: The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993;43:2412–2414.
25.
Brodaty H, Moore CM: The clock drawing test for dementia of the Alzheimer’s type: A comparison of three scoring methods in a memory disorders clinic. Int J Geriatr Psychiatry 1997;12:619–627.
26.
Ainslie NK, Murden RA: Effect of education on the clock-drawing dementia screen in non-demented elderly persons. J Am Geriatr Soc 1993;41:249–252.
27.
Royall DR, Cordes JA, Marsha P: CLOX: An executive clock drawing task. J Neurol Neurosurg Psychiatry 1998;64:588–594.
28.
Ferrucci L, Cecchi F, Guralnik JM, Giampaolis S, Lo Noce C, Salani B, Bamdinelli S: Does the Clock Drawing Test predict cognitive decline in older persons independent of the Mini-Mental State Examination? J Am Geriatr Soc 1996;44:1326–1331.
© 2003 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.